+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study



Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study



American Journal of Hematology 91(2): E3




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058802492

Download citation: RISBibTeXText

PMID: 26572233

DOI: 10.1002/ajh.24240


Related references

A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. American Journal of Hematology 89(6): 646-650, 2014

Tu1073 Evaluation of Ferumoxytol Treatment for Iron Deficiency Anemia in Patients With Gastrointestinal Disorders Who Have a History of Unsatisfactory Oral Iron Therapy: Results of a Phase Iii, Randomized, Placebo-Controlled Trial. Gastroenterology 144(5): S-754, 2013

Treatment of iron-deficiency anemia with IV ferumoxytol in CKD patients: Efficacy compared with oral iron across different age groups. 2007

Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron. American Journal of Hematology 89(1): 7-12, 2014

P074 Sustained Improvements In Fatigue And Quality Of Life In Patients With Ibd And Iron Deficiency Anemia Following A Single Course Of Ferumoxytol: Results Of A 6-Month Extension Study. Inflammatory Bowel Diseases 25(Suppl._1): S35-S36, 2019

Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study. American Journal of Gastroenterology 100(11): 2503-2509, 2005

Tu1743 Iv Iron Treatment of Iron Deficiency Anemia with Ferumoxytol in Patients with Inflammatory Bowel Disease Unable to Take Oral Iron: A Randomized Controlled Trial Versus Ferric Carboxymaltose. Gastroenterology 156(6): S-1107-S-1108, 2019

Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer. Journal of Blood Medicine 8: 199-209, 2017

P-143Efficacy and Safety of intravenous Ferumoxytol for the Treatment of Iron Deficiency Anemia in Patients with IBD. Inflammatory Bowel Diseases 19: S81-S82, 2013

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders. Clinical and Experimental Gastroenterology 9: 151-162, 2016

Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). Journal of Perinatal Medicine 45(4): 443-453, 2017

Safety and efficacy of intravenous ferric carboxymaltose in Japanese patients with iron-deficiency anemia caused by digestive diseases: an open-label, single-arm study. International Journal of Hematology 109(1): 50-58, 2019

Ferumoxytol: a new intravenous iron preparation for the treatment of iron deficiency anemia in patients with chronic kidney disease. PharmacoTherapy 30(1): 70-79, 2010

Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis. American Journal of Nephrology 39(2): 130-141, 2014

Mo1861 Utilization and Efficacy of Oral Iron Therapy in Patients With Iron Deficiency Anemia in a Nationwide Cohort of Ulcerative Colitis Patients. Gastroenterology 150(4): S797-S798, 2016